FierceBiotech Executive Summit

In a post-Brexit world, what is the U.K. doing to remain competitive in biomedical science?

As the U.K. approaches a future outside of the Europe Union, this event will look at the infrastructures of biomedical science in U.K. and the challenges and opportunities to boosting life sciences amid a time of major change.

Chief Business Officer Matthew Durdy will be takeing part in panel discussion titled Challenges and Opportunities for Life Science Post-Brexit.

Discover who we are